Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATNM

Actinium Pharmaceuticals Inc

0.9900

Jun 26 • 04:00PM ET +0.0400 (4.21%)

Healthcare Biotechnology USA Nano AMEX

Peers: ATOS GRCE INMB LTRN OTLK QNTM RNXT VERU XLO TLPH

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	0.60%	Shs Outstand	31.37M	Perf Week	-3.88%
Market Cap	31.06M	Forward P/E	-	EPS next Y	-0.82	Insider Trans	0.00%	Shs Float	31.19M	Perf Month	-16.10%
Enterprise Value	-9.55M	PEG	-	EPS next Q	-0.22	Inst Own	16.90%	Short Float	2.97%	Perf Quarter	-5.71%
Income	-23.47M	P/S	345.11	EPS this Y	22.32%	Inst Trans	-0.93%	Short Ratio	5.09	Perf Half Y	-37.34%
Sales	0.09M	P/B	13.48	EPS next Y	2.56%	ROA	-41.15%	Short Interest	0.93M	Perf YTD	-27.21%
Book/sh	0.07	P/C	0.74	EPS next 5Y	35.68%	ROE	-167.66%	52W High	1.89 -47.62%	Perf Year	-38.89%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-759.83%	52W Low	0.94 5.32%	Perf 3Y	-86.36%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-828.89%	Volatility	4.69% 6.27%	Perf 5Y	-88.23%
Dividend TTM	-	EV/Sales	-106.11	EPS Y/Y TTM	48.96%	Oper. Margin	-28346.67%	ATR (14)	0.06	Perf 10Y	-98.08%
Dividend Ex-Date	-	Quick Ratio	5.89	Sales Y/Y TTM	11.11%	Profit Margin	-26078.89%	RSI (14)	39.83	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.89	EPS Q/Q	65.39%	SMA20	-6.65%	Beta	0.02	Target Price	6.00
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	-15.46%	Rel Volume	0.69	Prev Close	0.95
Employees	25	LT Debt/Eq	0.34	Earnings	May 11	SMA200	-23.82%	Avg Volume	182.20K	Price	0.99
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.22% -	Trades		Volume	126,337	Change	4.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)